Statins reduce short- and long-term mortality associated with postoperative atrial fibrillation after coronary artery bypass grafting: Impact of postoperative atrial fibrillation and statin therapy on survival

Clinical Cardiology

Volumn 35, Issue 7, 2012, Pages 430-436

  Girerd, Nicolas ^a   Pibarot, Philippe ^a   Daleau, Pascal ^a   Voisine, Pierre ^a   O'Hara, Gilles ^a   Després, Jean Pierre ^a   Mathieu, Patrick ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; FEMALE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEART ATRIUM FIBRILLATION; RETROSPECTIVE STUDY; SURGICAL MORTALITY;

EID: 84863487307     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.21008     Document Type: Article

References (33)

1. Villareal RP, Hariharan R, Liu BC, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004; 43: 742-748. (Pubitemid 38296469)
2. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation. 1996; 94: 390-397. (Pubitemid 26266124)
3. Almassi GH, Schowalter T, Nicolosi AC, et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg. 1997; 226: 501-511; discussion 511-513.
4. Creswell LL, Schuessler RB, Rosenbloom M, et al. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993; 56: 539-549. (Pubitemid 23294415)
5. Filardo G, Hamilton C, Hebeler RF Jr, et al. New-onset postoperative atrial fibrillation after isolated coronary artery bypass graft surgery and long-term survival. Circ Cardiovasc Qual Outcomes. 2009; 2: 164-169.
6. Kalavrouziotis D, Buth KJ, Ali IS., The impact of new-onset atrial fibrillation on in-hospital mortality following cardiac surgery. Chest. 2007; 131: 833-839. (Pubitemid 46446877)
7. Mariscalco G, Engstrom KG., Postoperative atrial fibrillation is associated with late mortality after coronary surgery, but not after valvular surgery. Ann Thorac Surg. 2009; 88: 1871-1876.
8. Mariscalco G, Klersy C, Zanobini M, et al. Atrial fibrillation after isolated coronary surgery affects late survival. Circulation. 2008; 118: 1612-1618.
9. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004; 291: 1720-1729. (Pubitemid 38489894)
10. Stamou SC, Dangas G, Hill PC, et al. Atrial fibrillation after beating heart surgery. Am J Cardiol. 2000; 86: 64-67. (Pubitemid 30365145)
11. Bramer S, van Straten AH, Soliman Hamad MA, et al. The impact of new-onset postoperative atrial fibrillation on mortality after coronary artery bypass grafting. Ann Thorac Surg. 2010; 90: 443-449.
12. El-Chami MF, Kilgo P, Thourani V, et al. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. J Am Coll Cardiol. 55: 1370-1376.
13. Pan W, Pintar T, Anton J, et al. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004; 110: 1145-1149.
14. Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006; 114: 1455-1461. (Pubitemid 44526999)
15. Echahidi N, Pibarot P, O'Hara G, et al. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol. 2008; 51: 793-801. (Pubitemid 351255619)
16. Abdelhadi RH, Gurm HS, Van Wagoner DR, et al. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol. 2004; 93: 1176-1178. (Pubitemid 38521055)
17. Bruins P, te Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997; 96: 3542-3548. (Pubitemid 27513431)
18. Echahidi N, Pibarot P, Despres JP, et al. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol. 2007; 50: 843-851. (Pubitemid 47268739)
19. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation. 2004; 110: e340-e437.
20. van de Watering LM, Hermans J, Houbiers JG, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation. 1998; 97: 562-568. (Pubitemid 28090685)
21. Bramer S, van Straten AH, Soliman Hamad MA, et al. The impact of preoperative atrial fibrillation on early and late mortality after coronary artery bypass grafting. Eur J Cardiothorac Surg. 38: 373-379.
22. Kangasniemi OP, Biancari F, Luukkonen J, et al. Preoperative C-reactive protein is predictive of long-term outcome after coronary artery bypass surgery. Eur J Cardiothorac Surg. 2006; 29: 983-985.
23. Clark LL, Ikonomidis JS, Crawford FA Jr, et al. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. J Thorac Cardiovasc Surg. 2006; 131: 679-685.
24. Powell BD, Bybee KA, Valeti U, et al. Influence of preoperative lipid-lowering therapy on postoperative outcome in patients undergoing coronary artery bypass grafting. Am J Cardiol. 2007; 99: 785-789. (Pubitemid 46371397)
25. Ali IS, Buth KJ,: Preoperative statin use and outcomes following cardiac surgery. Int J Cardiol. 2005; 103: 12-18. (Pubitemid 41074598)
26. Subramaniam K, Koch CG, Bashour A, et al. Preoperative statin intake and morbid events after isolated coronary artery bypass grafting. J Clin Anesth. 2008; 20: 4-11. (Pubitemid 351381408)
27. Kulik A, Brookhart MA, Levin R, et al. Impact of statin use on outcomes after coronary artery bypass graft surgery. Circulation. 2008; 118: 1785-1792.
28. Liao JK., Beyond lipid lowering: the role of statins in vascular protection. Int J Cardiol. 2002; 86: 5-18. (Pubitemid 35247880)
29. Ramani G, Zahid M, Good CB, et al. Comparison of frequency of new-onset atrial fibrillation or flutter in patients on statins versus not on statins presenting with suspected acute coronary syndrome. Am J Cardiol. 2007; 100: 404-405. (Pubitemid 47094684)
30. Young-Xu Y, Jabbour S, Goldberg R, et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol. 2003; 92: 1379-1383. (Pubitemid 37532555)
31. Khanderia U, Townsend KA, Eagle K, et al. Statin initiation following coronary artery bypass grafting: outcome of a hospital discharge protocol. Chest. 2005; 127: 455-463. (Pubitemid 40229303)
32. Yam FK, Akers WS, Ferraris VA, et al. Interventions to improve guideline compliance following coronary artery bypass grafting. Surgery. 2006; 140: 541-547; discussion 547-552.
33. Ray KK, Cannon CP., The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol. 2005; 46: 1425-1433. (Pubitemid 41446176)